Current and historical daily PE Ratio for CellaVision AB (
) from 2010 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CellaVision AB stock (CLVSF) PE ratio as of May 12 2024 is 38.26.
More Details
CellaVision AB (CLVSF) PE Ratio (TTM) Chart
CellaVision AB (CLVSF) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1225
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| CellaVision AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-12 | 36.1 | 2024-03-08 | 32.3 |
| 2024-05-10 | 36.1 | 2024-03-07 | 32.3 |
| 2024-05-09 | 36.1 | 2024-03-06 | 32.3 |
| 2024-05-08 | 36.1 | 2024-03-05 | 32.3 |
| 2024-05-07 | 36.1 | 2024-03-04 | 32.3 |
| 2024-05-06 | 36.1 | 2024-03-01 | 32.3 |
| 2024-05-03 | 36.1 | 2024-02-29 | 32.3 |
| 2024-05-02 | 36.1 | 2024-02-28 | 32.3 |
| 2024-05-01 | 36.1 | 2024-02-27 | 32.3 |
| 2024-04-30 | 36.1 | 2024-02-26 | 32.3 |
| 2024-04-29 | 36.1 | 2024-02-23 | 32.3 |
| 2024-04-26 | 36.1 | 2024-02-22 | 32.3 |
| 2024-04-25 | 36.3 | 2024-02-21 | 32.3 |
| 2024-04-24 | 36.3 | 2024-02-20 | 32.3 |
| 2024-04-23 | 36.3 | 2024-02-16 | 32.3 |
| 2024-04-22 | 36.3 | 2024-02-15 | 32.3 |
| 2024-04-19 | 36.3 | 2024-02-14 | 32.3 |
| 2024-04-18 | 36.3 | 2024-02-13 | 32.3 |
| 2024-04-17 | 36.3 | 2024-02-12 | 32.3 |
| 2024-04-16 | 36.3 | 2024-02-09 | 32.3 |
| 2024-04-15 | 36.3 | 2024-02-08 | 32.3 |
| 2024-04-12 | 36.3 | 2024-02-07 | 32.3 |
| 2024-04-11 | 36.3 | 2024-02-06 | 32.3 |
| 2024-04-10 | 36.3 | 2024-02-05 | 32.3 |
| 2024-04-09 | 36.3 | 2024-02-02 | 32.3 |
| 2024-04-08 | 38.0 | 2024-02-01 | 32.3 |
| 2024-04-05 | 38.0 | 2024-01-31 | 32.3 |
| 2024-04-04 | 38.0 | 2024-01-30 | 32.3 |
| 2024-04-03 | 38.0 | 2024-01-29 | 32.3 |
| 2024-04-02 | 38.0 | 2024-01-26 | 32.3 |
| 2024-04-01 | 38.0 | 2024-01-25 | 32.3 |
| 2024-03-28 | 38.0 | 2024-01-24 | 32.3 |
| 2024-03-27 | 41.2 | 2024-01-23 | 32.3 |
| 2024-03-26 | 41.2 | 2024-01-22 | 32.3 |
| 2024-03-25 | 41.2 | 2024-01-19 | 32.3 |
| 2024-03-22 | 32.3 | 2024-01-18 | 32.3 |
| 2024-03-21 | 32.3 | 2024-01-17 | 32.3 |
| 2024-03-20 | 32.3 | 2024-01-16 | 32.3 |
| 2024-03-19 | 32.3 | 2024-01-12 | 32.3 |
| 2024-03-18 | 32.3 | 2024-01-11 | 32.3 |
| 2024-03-15 | 32.3 | 2024-01-10 | 32.3 |
| 2024-03-14 | 32.3 | 2024-01-09 | 32.3 |
| 2024-03-13 | 32.3 | 2024-01-08 | 32.3 |
| 2024-03-12 | 32.3 | 2024-01-05 | 32.3 |
| 2024-03-11 | 32.3 | 2024-01-04 | 32.3 |
CellaVision AB (CLVSF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CellaVision AB
ISIN : SE0000683484
Share Class Description:
CLVSF: Bearer ShsCompare
Compare
Traded in other countries / regions
CEVI.Sweden0MR5.UKCLVSF.USAC26.Germany IPO Date
2010-06-10Description
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers